Department of Pediatric Dentistry, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, China; Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Orthopaedic Surgery, Shengjing Hospital, China Medical University, Shenyang, China.
Bone. 2021 Jul;148:115905. doi: 10.1016/j.bone.2021.115905. Epub 2021 Mar 1.
Fracture healing is a multistage process characterized by inflammation, cartilage formation, bone deposition, and remodeling. Chondrocytes are important in producing cartilage that forms the initial anlagen for the hard callus needed to stabilize the fracture site. We examined the role of FOXO1 by selective ablation of FOXO1 in chondrocytes mediated by Col2α1 driven Cre recombinase. Experimental mice with lineage-specific FOXO1 deletion (Col2α1CreFOXO1) and negative control littermates (Col2α1CreFOXO1) were used for in vivo, closed fracture studies. Unexpectedly, we found that in the early phases of fracture healing, FOXO1 deletion significantly increased the amount of cartilage formed, whereas, in later periods, FOXO1 deletion led to a greater loss of cartilage. FOXO1 was functionally important as its deletion in chondrocytes led to diminished bone formation on day 22. Mechanistically, the early effects of FOXO1 deletion were linked to increased proliferation of chondrocytes through enhanced expression of cell cycle genes that promote proliferation and reduced expression of those that inhibit it and increased expression of cartilage matrix genes. At later time points experimental mice with FOXO1 deletion had greater loss of cartilage, enhanced formation of osteoclasts, increased IL-6 and reduced numbers of M2 macrophages. These results identify FOXO1 as a transcription factor that regulates chondrocyte behavior by limiting the early expansion of cartilage and preventing rapid cartilage loss at later phases.
骨折愈合是一个多阶段的过程,其特征为炎症、软骨形成、骨沉积和重塑。软骨细胞在产生软骨方面起着重要作用,软骨形成硬痂的初始前体,硬痂用于稳定骨折部位。我们通过 Col2α1 驱动的 Cre 重组酶介导的软骨细胞中 FOXO1 的选择性缺失来研究 FOXO1 的作用。用于体内闭合性骨折研究的具有谱系特异性 FOXO1 缺失(Col2α1CreFOXO1)的实验小鼠和阴性对照同窝仔(Col2α1CreFOXO1)。出乎意料的是,我们发现,在骨折愈合的早期阶段,FOXO1 缺失显著增加了形成的软骨量,而在后期,FOXO1 缺失导致更多的软骨丢失。FOXO1 的功能很重要,因为其在软骨细胞中的缺失导致第 22 天骨形成减少。从机制上讲,FOXO1 缺失的早期作用与通过增强促进增殖的细胞周期基因的表达和降低抑制其增殖的基因的表达以及增加软骨基质基因的表达来增加软骨细胞的增殖有关。在稍后的时间点,具有 FOXO1 缺失的实验小鼠具有更大的软骨损失、破骨细胞形成增加、IL-6 增加和 M2 巨噬细胞数量减少。这些结果表明 FOXO1 是一种转录因子,通过限制软骨的早期扩张和防止后期快速软骨丢失来调节软骨细胞行为。